SCHEMBL23747348

SCHEMBL23747348

CN1CCN(Cc2ccc(NC(=O)NCc3ccc(Cl)cc3)c(F)c2)C(=O)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C19 P33261 1/20 0.44
KMT2A Q03164 4/20 0.43
MEN1 O00255 3/20 0.43
MAPT P10636 3/20 0.42
POLB P06746 3/20 0.42
RAB9A P51151 2/20 0.42
ALDH1A1 P00352 1/20 0.42
HPGD P15428 1/20 0.41
CHRM1 P11229 1/20 0.41
HTR2A P28223 1/20 0.41
MCHR1 Q99705 1/20 0.41
TP53 P04637 2/20 0.40
NPC1 O15118 1/20 0.40
ENPP2 Q13822 1/20 0.40
HTT P42858 1/20 0.40
F10 P00742 1/20 0.39
DDR1 Q08345 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26101687 0.85 RAB9A (0.57) KMT2AMEN1POLBRAB9AHPGD
SCHEMBL23747349 0.83 RAB9A (0.48) CYP1A2CYP3A4CYP2C19KMT2AMEN1
SCHEMBL23747463 0.83 CHRM1 (0.45) CYP1A2CYP3A4CYP2D6CYP2C19KMT2A
SCHEMBL23747464 0.80 RAB9A (0.56) KMT2AMEN1MAPTPOLBRAB9A
SCHEMBL23727723 0.74 SMN1; SMN2 (0.58) KMT2AMEN1MAPTPOLBRAB9A
SCHEMBL23747447 0.72 RAB9A (0.54) KMT2AMEN1POLBRAB9AHPGD
SCHEMBL23728037 0.72 CHRM1 (0.55) KMT2AMEN1MAPTPOLBRAB9A
SCHEMBL23747781 0.72 CYP1A2 (0.49) CYP1A2CYP3A4CYP2D6CYP2C19KMT2A
SCHEMBL23747740 0.70 L3MBTL1 (0.40) CYP1A2CYP2C19KMT2AMEN1RAB9A
SCHEMBL15858005 0.70 ALDH1A1 (0.53) KMT2AMEN1POLBRAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230133132-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-05-04 US disclosed
US-20230133132-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-05-04 US disclosed
US-20230133132-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-05-04 US disclosed
WO-2021159015-A1 NAMPT MODULATORS CYTOKINETICS, INC. (US) 2021-08-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230133132-A1 NAMPT MODULATORS NAMPT, MC4R, SIRT1 CYP1A2 2420/4885CYP3A4 2794/4885CYP2D6 2623/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.